IDEXX LABORATORIES INC (IDXX) Income statement

Market cap

$45.8B

P/E ratio

Summary Financials

Income statement Balance sheet Cash flow Other

	2010/12	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Revenue	1,103	-	1,293	1,377	1,486	1,602	1,775	1,969	2,213	2,407	2,707	3,215	3,367	3,661	3,898
Revenue growth (%)	-	-	-
Cost of revenue	525	-	594	621	670	712	800	872	972	1,041	1,136	1,326	1,363	1,471	1,519
Gross profit	579	-	699	756	816	890	975	1,097	1,242	1,366	1,571	1,889	2,004	2,190	2,379
Gross margin (%)		-
Research & development	69	-	82	88	98	100	101	109	118	133	141	161	255	191	220
Operating margin (%)		-
Operating expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,251
Operating income	204	-	263	267	260	300	350	413	491	553	695	932	899	1,097	1,128
Income before tax	202	-	261	263	247	273	322	381	458	522	662	903	860	1,061	1,110
Pretax margin (%)	18.3	-	20.2	19.1	16.6	17.1	18.1	19.4	20.7	21.7	24.5	28.1	25.5	29	28.5
Provision for income taxes	61	-	82	75	65	81	100	118	81	94	80	158	181	216	222
Effective tax rate (%)		-
Net income	141	162	178	188	182	192	222	263	377	428	582	745	679	845	888
Net income margin (%)		-
Earnings per share	2.45	-	3.24	3.53	3.63	2.07	2.47	3	4.34	4.97	6.82	8.74	8.12	10.17	10.77
Diluted EPS	2.37	-	3.17	3.48	3.58	2.05	2.44	2.94	4.26	4.89	6.71	8.6	8.03	10.06	10.67
EBITDA		-
EBITDA margin (%)		-